AlenCiken

Granted FDA Emergency Use Authorization

NASDAQ:FLDM   None
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

-Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment

-Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System

-Demonstrated 100 Percent Agreement with Authorized Nasopharyngeal Assays

finance.yahoo.com/ne...ation-030000078.html

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。